We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DNR
1651
DELISTED
Denbury Resources, Inc.
DNR
| $155K | ﹤0.01% |
562,389
-1,710,299
| -75% | -$514K |
|
|
K
1652
DELISTED
Kellanova
K
| $154K | ﹤0.01% |
2,488
-638
| -20% | -$38.6K |
|
1653
Encore Capital Group
ECPG
$2.14B
| $151K | ﹤0.01% |
+4,420
| New | +$132K |
|
1654
CMS Energy
CMS
$20.7B
| $150K | ﹤0.01% |
2,557
-2,574
| -50% | -$149K |
|
|
CSW
1655
CSW Industrials
CSW
$4.65B
| $150K | ﹤0.01% |
2,158
-288
| -12% | -$19.4K |
|
|
FEAC.WS
1656
DELISTED
Flying Eagle Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A com
FEAC.WS
| $150K | ﹤0.01% |
+50,000
| New | +$105K |
|
1657
Gen Digital
GEN
$18.4B
| $149K | ﹤0.01% |
7,516
-29,077
| -79% | -$592K |
|
1658
Hartford Financial Services
HIG
$36.2B
| $149K | ﹤0.01% |
3,861
-134,406
| -97% | -$5.12M |
|
1659
Lumen
LUMN
$6.88B
| $148K | ﹤0.01% |
14,840
-276,729
| -95% | -$2.77M |
|
1660
Principal Financial Group
PFG
$25.2B
| $148K | ﹤0.01% |
3,588
+408
| +13% | +$14.9K |
|
1661
VICI Properties
VICI
$26.6B
| $145K | ﹤0.01% |
+7,200
| New | +$132K |
|
|
DENN
1662
DELISTED
Denny's
DENN
| $141K | ﹤0.01% |
13,962
-261,725
| -95% | -$2.69M |
|
1663
Zebra Technologies
ZBRA
$16.4B
| $141K | ﹤0.01% |
+550
| New | +$129K |
|
|
LGF.A
1664
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $141K | ﹤0.01% |
18,973
-1,874
| -9% | -$13.9K |
|
|
DCPH
1665
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $141K | ﹤0.01% |
2,355
-196,148
| -99% | -$10.5M |
|
1666
Avis
CAR
$4.07B
| $140K | ﹤0.01% |
6,081
-10,643
| -64% | -$195K |
|
1667
Norwegian Cruise Line
NCLH
$6.66B
| $140K | ﹤0.01% |
8,502
-1,129,001
| -99% | -$16.5M |
|
1668
RPC Inc
RES
$1.32B
| $139K | ﹤0.01% |
45,128
-1,129,151
| -96% | -$3.44M |
|
1669
Quest Diagnostics
DGX
$27.3B
| $138K | ﹤0.01% |
1,216
+88
| +8% | +$9.33K |
|
1670
Brown-Forman Class B
BF.B
$12B
| $134K | ﹤0.01% |
2,101
-3,489
| -62% | -$223K |
|
1671
Western Digital
WDC
$153B
| $134K | ﹤0.01% |
4,001
+94
| +2% | +$3.04K |
|
1672
Monster Beverage
MNST
$86.9B
| $133K | ﹤0.01% |
7,652
-86,156
| -92% | -$1.41M |
|
1673
Heritage Insurance Holdings
HRTG
$1.04B
| $132K | ﹤0.01% |
10,068
+227
| +2% | +$2.66K |
|
1674
Personalis
PSNL
$1.73B
| $130K | ﹤0.01% |
10,000
-50,000
| -83% | -$555K |
|
1675
Johnson Controls International
JCI
$85.7B
| $129K | ﹤0.01% |
3,773
-3,375
| -47% | -$104K |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.